Apolipoprotein E polymorphism in childhood nephrotic syndrome

被引:19
|
作者
Attila, G [1 ]
Noyan, A
Bayazit, AK
Acartürk, E
Anarat, A
机构
[1] Cukurova Univ, Sch Med, Dept Biochem, TR-01330 Adana, Turkey
[2] Cukurova Univ, Sch Med, Dept Pediat Nephrol, TR-01330 Adana, Turkey
[3] Cukurova Univ, Sch Med, Dept Cardiol, TR-01330 Adana, Turkey
关键词
ApoE polymorphism; nephrotic syndrome;
D O I
10.1007/s00467-001-0802-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Recent clinical reports have demonstrated that the progression and prognosis of renal diseases are possibly influenced by apolipoprotein E (apoE) genotypes and alleles. In this study we investigated whether apoE genotypes and alleles can be a prognostic criterion for the steroid responsiveness in childhood nephrotic syndrome. One hundred and seven pediatric patients with primary idiopathic nephrotic syndrome and 83 healthy volunteers were enrolled in the study. Eighty-seven of the patients had steroid-sensitive nephrotic syndrome (SSNS) and 20 had steroid-resistant nephrotic syndrome (SRNS). The epsilon2 allele frequency and epsilon2/3 genotype frequency of the SNRS group were statistically higher when compared with SSNS and control groups (P<0.05). The higher frequency of the epsilon2 allele in steroid resistant nephrotic patients suggests that the epsilon2 allele gives a possible genetic predisposition to steroid resistance in our population, but further studies are needed to clarify this subject.
引用
收藏
页码:359 / 362
页数:4
相关论文
共 50 条
  • [41] Emerging pharmacotherapies for the treatment of childhood nephrotic syndrome
    Salmon, Eloise
    Trachtman, Howard
    EXPERT OPINION ON PHARMACOTHERAPY, 2025,
  • [42] Histopathological spectrum of childhood nephrotic syndrome in Pakistan
    Muhammed Mubarak
    Ali Lanewala
    Javed Iqbal Kazi
    Fazal Akhter
    Atika Sher
    Amir Fayyaz
    Sajid Bhatti
    Clinical and Experimental Nephrology, 2009, 13 : 589 - 593
  • [43] The autoimmune architecture of childhood idiopathic nephrotic syndrome
    Al-Aubodah, Tho-Alfakar
    Piccirillo, Ciriaco A.
    Trachtman, Howard
    Takano, Tomoko
    KIDNEY INTERNATIONAL, 2025, 107 (02) : 271 - 279
  • [44] Implication of serum IgE in childhood nephrotic syndrome
    Tain, YL
    Chen, TY
    Yang, KD
    PEDIATRIC NEPHROLOGY, 2003, 18 (12) : 1211 - 1215
  • [45] Cyclosporine versus Cyclophosphamide in Childhood Nephrotic Syndrome
    Khemani, Sunita
    Moorani, Khemchand N.
    JOURNAL OF THE LIAQUAT UNIVERSITY OF MEDICAL AND HEALTH SCIENCES, 2016, 15 (02): : 57 - 62
  • [46] Unanswered questions in childhood idiopathic nephrotic syndrome
    Lanewala, Ali
    Mubarak, Muhammed
    JOURNAL OF RENAL INJURY PREVENTION, 2014, 3 (01): : 1 - 2
  • [47] Risk factors for relapse in childhood nephrotic syndrome
    Takeda, A
    Matsutani, H
    Niimura, F
    Ohgushi, H
    PEDIATRIC NEPHROLOGY, 1996, 10 (06) : 740 - 741
  • [48] Rituximab for troublesome cases of childhood nephrotic syndrome
    Osama Y Safdar
    Adila Aboualhameael
    Jameela A Kari
    World Journal of Clinical Pediatrics, 2014, (04) : 69 - 75
  • [49] Levamisole and ANCA positivity in childhood nephrotic syndrome
    Krischock, Leah
    Pannila, Pasan
    Kennedy, Sean E.
    PEDIATRIC NEPHROLOGY, 2021, 36 (07) : 1795 - 1802
  • [50] Is rituximab effective in childhood nephrotic syndrome? Yes and no
    Markus J. Kemper
    Anja Lehnhardt
    Anna Zawischa
    Jun Oh
    Pediatric Nephrology, 2014, 29 : 1305 - 1311